Dr. Ishita B. Sen

• Presidency of the Association of Nuclear Medicine Physicians of India (ANMPI).
• Appointment to the International Task Force by the IAEA, Vienna.
• Regular invitations to speak at prestigious national and international medical conferences.

Authored and co-authored numerous reviews, clinical communications, original articles, and abstracts in peer-reviewed national and international journals (25+ publications listed on ResearchGate).A few are mentioned below:

• “Validation of Radiosynthesis and First in-Human Dosimetry of 68 Ga-NOTA-UBI-29-41: A Proof of Concept Study” (Nov 2024)
• “Potential Efficacy of 68 Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal Adenocarcinoma” (Jun 2024)
• “Dosimetric analyses of intra-arterial versus standard intravenous administration of 177Lu-DOTATATE in patients of well differentiated neuroendocrine tumor with liver-dominant metastatic disease” (Aug 2021)
• “Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy” (May 2021)
• “Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate Cancer” (Apr 2020)
• “Potential role of F18 FDG PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: a prospective clinical observational study” (Jul 2014)
• “Role of F-18-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma” (May 2013)

Books & Chapters Authored:

• Chapter: “Molecular Imaging in Oncology” (Jan 2016) – Co-author
• Chapter: “The Role of PET/CT in Prostate Cancer Management” (Jul 2017) – Co-author

Treatment Costs: Costs for procedures like PET/CT scans and Radionuclide Therapies (PRRT, Radioiodine, etc.) vary significantly based on the type of scan/therapy, radiopharmaceutical used, number of cycles required, and hospital charges. A detailed estimate is typically provided after consultation and assessment.

• Language Support: You can contact Cancer Rounds team for translators for language assistance upon request.
• Visa & Travel Assistance: Cancer Rounds team assists with visa invitation letters, travel arrangements, airport transfers, and accommodation bookings. International patients are typically assigned a dedicated coordinator to manage appointments, logistics, and communication.
• Pre-treatment Virtual Consultations: Available to review medical reports, discuss potential diagnostic or therapeutic options in Nuclear Medicine, and provide preliminary opinions before travel.

Notable Cases Handled:

• Successful management of complex Thyroid Cancer cases using Radioiodine therapy post-surgery.
• Accurate staging and restaging of Prostate Cancer using advanced Ga-68 PSMA PET/CT, guiding further treatment decisions.
• Effective treatment of metastatic Neuroendocrine Tumors (NETs) using Peptide Receptor Radionuclide Therapy (PRRT) with Lu-177 DOTATATE, improving quality of life and survival.
• Pioneering use of targeted alpha therapy (Ac-225 PSMA) for metastatic castration-resistant prostate cancer patients with limited options.
• Precise localization of infections and inflammatory processes using FDG-PET/CT and FDG-labelled leukocyte scans.

Patient Testimonials:

“Dr. Ishita Sen and her team were exceptional. After my father was diagnosed with advanced prostate cancer, the PSMA PET scan they performed was crucial for understanding the disease spread. We are grateful for her expertise and compassionate care.” – R. Sharma “I was diagnosed with a neuroendocrine tumor, and the Lu-177 DOTATATE PRRT under Dr. Sen’s supervision has made a world of difference. Her clear explanations and confident approach were very reassuring throughout the treatment process. The follow-up scans show a great response.” – A. Khan “I highly recommend Dr. Sen for advanced radiotherapy cancer treatments.” — Rahul K.

Patient-Centred Care: Dr. Sen, Nuclear Oncologist emphasizes a patient-centric approach, ensuring patients understand their diagnosis, imaging results, and treatment options. She focuses on providing clear communication and compassionate care. She works closely with referring physicians (Oncologists, Surgeons, Endocrinologists, etc.) within a multidisciplinary team framework to ensure comprehensive and personalized patient management. Technology & Innovation: She leverages state-of-the-art Nuclear Medicine technology (PET/CT, SPECT/CT) and novel radiopharmaceuticals for accurate diagnosis, staging, treatment response assessment, and targeted radionuclide therapies. She specializes in targeted therapies (like PRRT and PSMA therapy) that deliver radiation specifically to cancer cells, minimizing damage to healthy tissues.